| First Author | Nagata S | Year | 1995 |
| Journal | Immunol Today | Volume | 16 |
| Issue | 1 | Pages | 39-43 |
| PubMed ID | 7533498 | Mgi Jnum | J:22375 |
| Mgi Id | MGI:70249 | Doi | 10.1016/0167-5699(95)80069-7 |
| Citation | Nagata S, et al. (1995) Fas and Fas ligand: lpr and gld mutations. Immunol Today 16(1):39-43 |
| abstractText | Fas ligand (FasL) is a death factor that binds to its receptor, Fas, and induces apoptosis. Two mutations that accelerate autoimmune disease, lpr and gld, are known to correspond to mutations within genes encoding Fas and FasL, respectively. Here, Shigekazu Nagata and Takashi Suda summarize current knowledge of Fas and FasL, and discuss the physiological role of the Fas system in T-cell development, cytotoxicity and cytotoxic T lymphocyte (CTL)-mediated autoimmune disease. |
